Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database

Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database

ObjectiveThis study aimed to evaluate the risk of tumor formation with infliximab or azathioprine monotherapy versus their combination, using the FDA Adverse Event Reporting System (FAERS) database.MethodsData were extracted from the FAERS database for patients treated with infliximab, azathioprine,...

Full description

Bibliographic Details
Main Authors: Qian Qiao, Jiachen Sun, Ya Zheng, Yingying Mi, Yanan Gong, Jiahui Liu, Wenyue Rui, Yumei Ma, Yongning Zhou, Min Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
infliximab
azathioprine
combined treatment
tumor
adverse event
FAERS
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1507196/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1507196/full

Similar Items